Introduction: Glucocorticoids represent the standard therapy for reducing inflammation and
immune activation in various diseases. However, as with any potent medication, they are not …

There is convincing evidence for the known and unambiguously accepted beneficial effects
of glucocorticoids at low dosages. However, the implementation of existing …

Objectives: Review the anti-inflammatory, anti-proliferative, and immunosuppressive actions
of corticosteroids. Summarize the monitoring required for corticosteroid therapy. Describe …

Context: Various drugs affect body weight as a side effect. Objective: We conducted this
systematic review and meta-analysis to summarize the evidence about commonly …

Systemic corticosteroids play an integral role in the management of many inflammatory and
immunologic conditions, but these agents are also associated with serious risks …

In this article, the 2010 European League against Rheumatism (EULAR) recommendations
for the management of rheumatoid arthritis (RA) with synthetic and biological disease …

Objectives: To develop evidence-based EULAR recommendations for cardiovascular (CV)
risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and …

Objectives To update the evidence for the safety of synthetic disease-modifying
antirheumatic drugs (sDMARDs), glucocorticoids (GC) and biological DMARDs (bDMARDs) …

It is estimated that 2% to 3% of the population are currently prescribed systemic or topical
glucocorticoid treatment. The potent anti-inflammatory action of glucocorticoids to deliver …

Methods. In a multicenter, randomized clinical trial, 508 patients were allocated to 1 of 4
treatment strategies: sequential disease-modifying antirheumatic drug monotherapy (group …